Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies.

The synthesis of cryptolepine derivatives containing basic side-chains at the C-11 position and their evaluations for antiplasmodial and cytotoxicity properties are reported. Propyl, butyl, and cycloalkyl diamine side chains significantly increased activity against chloroquine-resistant Plasmodium falciparum strains while reducing cytotoxicity when compared with the parent compound. Localization studies inside parasite blood stages by fluorescence microscopy showed that these derivatives accumulate inside the nucleus, indicating that the incorporation of a basic side chain is not sufficient enough to promote selective accumulation in the acidic digestive vacuole of the parasite. Most of the compounds within this series showed the ability to bind to a double-stranded DNA duplex as well to monomeric hematin, suggesting that these are possible targets associated with the observed antimalarial activity. Overall, these novel cryptolepine analogues with substantially improved antiplasmodial activity and selectivity index provide a promising starting point for development of potent and highly selective agents against drug-resistant malaria parasites.

[1]  V. Yardley,et al.  Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA. , 2010, Journal of medicinal chemistry.

[2]  Kirandeep Kaur,et al.  Antimalarials from nature. , 2009, Bioorganic & medicinal chemistry.

[3]  Vipan Kumar,et al.  Synthetic medicinal chemistry of selected antimalarial natural products. , 2009, Bioorganic & medicinal chemistry.

[4]  S. Parapini,et al.  Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquine. , 2009, Journal of medicinal chemistry.

[5]  A. Krettli,et al.  Testing of natural products and synthetic molecules aiming at new antimalarials. , 2009, Current drug targets.

[6]  C. Davis,et al.  Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century. , 2009, Journal of medicinal chemistry.

[7]  S. Meshnick,et al.  Recent highlights in antimalarial drug resistance and chemotherapy research. , 2008, Trends in parasitology.

[8]  I. Weissbuch,et al.  Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design. , 2008, Chemical reviews.

[9]  P. Roepe,et al.  Quinine and chloroquine differentially perturb heme monomer-dimer equilibrium. , 2008, Inorganic chemistry.

[10]  S. Ablordeppey,et al.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships. , 2008, Mini reviews in medicinal chemistry.

[11]  A. Martinelli,et al.  Malaria combination therapies: advantages and shortcomings. , 2008, Mini reviews in medicinal chemistry.

[12]  J. Gut,et al.  Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity. , 2008, Bioorganic & medicinal chemistry letters.

[13]  Ruth H. Hughes,et al.  Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. , 2007, Angewandte Chemie.

[14]  M. Mota,et al.  Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry , 2007, Cellular microbiology.

[15]  C. Wright.  Recent developments in naturally derived antimalarials: cryptolepine analogues , 2007, The Journal of pharmacy and pharmacology.

[16]  B. K. Park,et al.  A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs. , 2006, Current topics in medicinal chemistry.

[17]  S. Croft,et al.  Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action. , 2005, Journal of medicinal chemistry.

[18]  N. Gooderham,et al.  In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. , 2005, Toxicology.

[19]  P. Rosenthal,et al.  Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.

[20]  Ruth H. Hughes,et al.  Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarials. , 2003, Journal of medicinal chemistry.

[21]  N. Gooderham,et al.  The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  M. Peterson,et al.  Quinoline Binding Site on Malaria Pigment Crystal: A Rational Pathway for Antimalaria Drug Design , 2002 .

[23]  M. Sajid,et al.  Cysteine proteases of parasitic organisms. , 2002, Molecular and biochemical parasitology.

[24]  Robert G. Ridley,et al.  Medical need, scientific opportunity and the drive for antimalarial drugs , 2002, Nature.

[25]  D. Hinrichs,et al.  Optimization of Xanthones for Antimalarial Activity: the 3,6-Bis-ω-Diethylaminoalkoxyxanthone Series , 2002, Antimicrobial Agents and Chemotherapy.

[26]  S. Croft,et al.  Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. , 2001, Journal of medicinal chemistry.

[27]  Virander S. Chauhan,et al.  Mechanism of malarial haem detoxification inhibition by chloroquine. , 2001, The Biochemical journal.

[28]  P. Grellier,et al.  New Synthesis of Benzo-δ-carbolines, Cryptolepines, and Their Salts: In Vitro Cytotoxic, Antiplasmodial, and Antitrypanosomal Activities of δ-Carbolines, Benzo-δ-carbolines, and Cryptolepines , 2001 .

[29]  J. Vennerstrom,et al.  Characterization of chloroquine-hematin mu-oxo dimer binding by isothermal titration calorimetry. , 2000, Biochimica et biophysica acta.

[30]  D. Warhurst,et al.  Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots. , 2000, Planta medica.

[31]  L. Angenot,et al.  Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine. , 1999, Biochemistry.

[32]  T. Eggelte,et al.  Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. , 1999, Trends in pharmacological sciences.

[33]  P. Rosenthal,et al.  Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. , 1999, Bioorganic & medicinal chemistry.

[34]  D. Krogstad,et al.  Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. , 1998, Journal of medicinal chemistry.

[35]  S. Ward,et al.  Access to hematin: the basis of chloroquine resistance. , 1998, Molecular pharmacology.

[36]  P. Imbach,et al.  Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. , 1998, Journal of medicinal chemistry.

[37]  L. Angenot,et al.  The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. , 1998, Biochemistry.

[38]  S. Ward,et al.  Relationship between Antimalarial Drug Activity, Accumulation, and Inhibition of Heme Polymerization in Plasmodium falciparum In Vitro , 1998, Antimicrobial Agents and Chemotherapy.

[39]  P. Imbach,et al.  Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities. , 1998, Journal of medicinal chemistry.

[40]  T. Egan,et al.  Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. , 1997, Journal of inorganic biochemistry.

[41]  H. Matile,et al.  4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum , 1996, Antimicrobial agents and chemotherapy.

[42]  H. Marques,et al.  Coordination of N-donor ligands by hematohemin , 1992 .

[43]  L. Marzilli,et al.  Porphyrin and metalloporphyrin binding to DNA polymers: rate and equilibrium binding studies. , 1988, Biochemistry.

[44]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[45]  P. Maccarthy,et al.  Novel approach to Job's method: an undergraduate experiment , 1986 .

[46]  K. Goerlitzer,et al.  FUSED QUINOLINES. V: 10-HYDROXY-10H-INDOLO(3,2-B)QUINOLINE 5-OXIDE (“DIOXYQUINDOLINE”) , 1982 .

[47]  K. Goerlitzer,et al.  FUSED QUINOLINES. VI: 10H-INDOLO(3,2-B)QUINOLINES , 1982 .

[48]  K. Ingham.  On the application of Job's method of continuous variation to the stoichiometry of protein-ligand complexes. , 1975, Analytical biochemistry.

[49]  M. Wahlgren,et al.  METHODS IN MALARIA RESEARCH , 2008 .

[50]  S. Ward,et al.  Quinolines and artemisinin: chemistry, biology and history. , 2005, Current topics in microbiology and immunology.

[51]  T. Egan,et al.  Effects of solvent composition and ionic strength on the interaction of quinoline antimalarials with ferriprotoporphyrin IX. , 2004, Journal of inorganic biochemistry.

[52]  Juan Aymami,et al.  The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites , 2002, Nature Structural Biology.

[53]  P. Grellier,et al.  New synthesis of benzo-delta-carbolines, cryptolepines, and their salts: in vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of delta-carbolines, benzo-delta-carbolines, and cryptolepines. , 2001, Journal of medicinal chemistry.

[54]  P. Turpin,et al.  Binding of the cationic 5‐coordinate Zn(II)‐5,10,15,20‐tetrakis(4‐N‐methylpyridyl)porphyrin to DNA and model polynucleotides: Ionic‐strength dependent intercalation in [poly(dG‐dC)]2 , 1999 .

[55]  B. K. Park,et al.  4-Aminoquinolines--past, present, and future: a chemical perspective. , 1998, Pharmacology & therapeutics.

[56]  C. Y. Huang.  Determination of binding stoichiometry by the continuous variation method: the Job plot. , 1982, Methods in enzymology.

[57]  J. Weber,et al.  Anellierte Chinoline, 6. Mitt. 10H‐Indolo[3,2‐b]chinoline , 1981 .

[58]  J. Derisi,et al.  Incorporation of an Intramolecular Hydrogen-bonding Motif in the Side Chain of 4-aminoquinolines Enhances Activity against Drug-resistant P. Falciparum , 2022 .